Reduced muscarinic cholinergic2 receptor binding in bipolar disorder using PET and [F-18]FP-TZTP

被引：0
|
作者：
Cannon, DM
Nugent, AC
Carson, RE
Eckelman, WC
Kiesewetter, D
Bain, EE
Solorio, G
Charney, D
Drevets, WC
机构：
[1] NIMH, NIH, Bethesda, MD 20892 USA
[2] NIH, Ctr Clin, Bethesda, MD 20892 USA
来源：
NEUROIMAGE | 2004年 / 22卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：T41 / T42
页数：2
相关论文
共 50 条
  • [21] Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder
    D M Cannon
    J K Klaver
    S K Gandhi
    G Solorio
    S A Peck
    K Erickson
    J Savitz N Akula
    W C Eckelman
    M L Furey
    B J Sahakian
    F J McMahon
    W C Drevets
    Molecular Psychiatry, 2011, 16 : 407 - 418
  • [22] Regional brain uptake of the muscarinic ligand, [18F]FP-TZTP, is decreased in M2 knockout but not in M4 knockout mice.
    Jagoda, EM
    Kiesewetter, DO
    Shimoji, K
    Gomeza, J
    Wess, J
    Eckelman, WC
    LIFE SCIENCES, 2001, 68 (22-23) : 2634 - 2634
  • [23] Reduced 5-HT1A receptor binding with [F-18]-FCWAY in bipolar depression
    Bain, EE
    Nugent, A
    Carson, RE
    Lang, LX
    Eckelman, W
    Neumeister, A
    Bonne, O
    Charney, DS
    Drevets, WC
    NEUROIMAGE, 2004, 22 : T167 - T168
  • [24] Determination of [18F]FCWAY, [18F]FP-TZTP, and their metabolites in plasma using rapid and efficient liquid-liquid and solid phase extractions
    Ma, Y
    Kiesewetter, DO
    Lang, LX
    Der, M
    Huang, B
    Carson, RE
    Eckelman, WC
    NUCLEAR MEDICINE AND BIOLOGY, 2003, 30 (03) : 233 - 240
  • [25] [F-18]-(-,-)-FQNPe - An attractive ligand for evaluation of muscarinic-cholinergic neuron acitivity by PET
    Luo, H
    McPherson, DW
    Beets, AL
    Knapp, FFR
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 238 - 238
  • [26] Regional brain uptake of the muscarinic ligand, [18F]FP-TZTP, is greatly decreased in M2 receptor knockout mice but not in M1, M3 and M4 receptor knockout mice
    Jagoda, EM
    Kiesewetter, DO
    Shimoji, K
    Ravasi, L
    Yamada, M
    Gomeza, J
    Wess, J
    Eckelman, WC
    NEUROPHARMACOLOGY, 2003, 44 (05) : 653 - 661
  • [27] PET IMAGING OF OPIATE RECEPTOR-BINDING IN HUMAN EPILEPSY USING [F-18] CYCLOFOXY
    THEODORE, WH
    CARSON, RE
    ANDREASEN, P
    ZAMETKIN, A
    BLASBERG, R
    LEIDERMAN, DB
    RICE, K
    NEWMAN, A
    CHANNING, M
    DUNN, B
    SIMPSON, N
    HERSCOVITCH, P
    EPILEPSY RESEARCH, 1992, 13 (02) : 129 - 139
  • [28] F-18(+)FP-DTBZ: a PET ligand for imaging VMAT2 binding sites in the brain and pancreas
    Kung, H.
    Kung, M. P.
    Lieberman, B.
    Hou, C.
    Ponde, D.
    Goswami, R.
    Skovraonsky, D.
    Deng, S.
    Markamnn, J.
    Kilborn, M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [29] Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder (vol 63, pg 741, 2006)
    Cannon, D. M.
    ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (11) : 1208 - 1208
  • [30] A polymorphism in the cholinergic M2-receptor gene may underlie reduced M2-receptor binding in bipolar disorder
    Cannon, Dara M.
    Klaver, Jacqueline M.
    Gandhi, Shilpa K.
    Solorio, Gerardo
    Eckelman, William C.
    Savitz, Jonathan
    Akula, Nirmala
    McMahon, Francis J.
    Drevets, Wayne C.
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 57S - 57S
12345